HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark W Geraci Selected Research

Dinoprostone (PGE2)

3/2007Genetic and epigenetic regulation of the human prostacyclin synthase promoter in lung cancer cell lines.
7/2006Prostaglandin E2 receptor subtype 2 (EP2) null mice are protected against murine lung tumorigenesis.
1/2005Targeted over-expression of mPGES-1 and elevated PGE2 production is not sufficient for lung tumorigenesis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark W Geraci Research Topics

Disease

14Lung Neoplasms (Lung Cancer)
10/2019 - 02/2002
12Neoplasms (Cancer)
01/2018 - 01/2002
8Carcinogenesis
01/2018 - 02/2002
7Pulmonary Arterial Hypertension
01/2023 - 12/2005
6Pulmonary Hypertension
10/2019 - 05/2002
5Inflammation (Inflammations)
10/2019 - 12/2004
4Adenocarcinoma
01/2018 - 08/2004
4Infections
12/2008 - 09/2003
4Lung Diseases (Lung Disease)
11/2008 - 05/2002
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2008 - 02/2005
4Emphysema
04/2007 - 05/2002
3COVID-19
01/2023 - 01/2023
3Hypoxia (Hypoxemia)
10/2019 - 05/2002
3Pneumonia (Pneumonitis)
11/2008 - 12/2004
2Chronic Obstructive Pulmonary Disease (COPD)
11/2023 - 04/2007
2Vascular Diseases (Vascular Disease)
01/2022 - 01/2021
2Adenocarcinoma of Lung
11/2021 - 01/2008
2Familial Primary Pulmonary Hypertension
01/2016 - 05/2002
2Virus Diseases (Viral Diseases)
01/2016 - 09/2003
2Sepsis (Septicemia)
08/2012 - 12/2004
2Neoplasm Metastasis (Metastasis)
03/2009 - 02/2005
2Vascular Remodeling
05/2003 - 05/2002
1Hemorrhage
01/2023
1Venous Thromboembolism
01/2023
1Critical Illness (Critically Ill)
01/2023
1Acidosis
10/2019
1Primary Graft Dysfunction
10/2019
1Reperfusion Injury
10/2019
1Tuberculosis (Tuberculoses)
02/2016
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2016
1Genomic Instability
02/2014
1Respiratory Insufficiency (Respiratory Failure)
08/2012
1Endotoxemia
08/2012
1Systemic Scleroderma (Systemic Sclerosis)
05/2011
1Cardiovascular Diseases (Cardiovascular Disease)
05/2011
1Disease Progression
01/2010

Drug/Important Bio-Agent (IBA)

9prostacyclin synthetase (prostacyclin synthase)IBA
01/2018 - 02/2002
9Epoprostenol (Prostacyclin)FDA LinkGeneric
01/2018 - 05/2004
5EicosanoidsIBA
01/2018 - 02/2002
5PPAR gammaIBA
01/2018 - 11/2002
5Proteins (Proteins, Gene)FDA Link
12/2008 - 05/2002
5CarcinogensIBA
10/2008 - 02/2002
4Biomarkers (Surrogate Marker)IBA
01/2021 - 10/2010
4CytokinesIBA
10/2019 - 08/2004
4Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
04/2007 - 02/2002
3EnzymesIBA
01/2016 - 01/2005
3Iloprost (Ventavis)FDA Link
06/2011 - 10/2008
3SmokeIBA
10/2008 - 08/2004
3Urethane (Ethyl Carbamate)IBA
01/2008 - 01/2005
3Dinoprostone (PGE2)FDA Link
03/2007 - 01/2005
3ProstaglandinsIBA
07/2006 - 08/2004
2MicroRNAs (MicroRNA)IBA
11/2023 - 11/2006
2RNA (Ribonucleic Acid)IBA
11/2023 - 11/2008
2Phosphotransferases (Kinase)IBA
06/2009 - 05/2002
2Phospholipases (Phospholipase)IBA
03/2009 - 11/2002
2Peptide Hydrolases (Proteases)FDA Link
01/2008 - 12/2004
2Messenger RNA (mRNA)IBA
01/2008 - 05/2002
2Arachidonic Acid (Vitamin F)IBA
03/2007 - 01/2005
2Prostaglandin-E SynthasesIBA
03/2007 - 01/2005
2Butylated Hydroxytoluene (BHT)IBA
06/2006 - 01/2005
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2004 - 05/2002
1Protein Isoforms (Isoforms)IBA
11/2023
1apixabanIBA
01/2023
1Monoclonal AntibodiesIBA
01/2023
1von Willebrand FactorIBA
01/2023
1P-SelectinIBA
01/2023
1crizanlizumabIBA
01/2023
1ThiazolidinedionesIBA
10/2019
1Collagen Type V (Type V Collagen)IBA
10/2019
1Semaxinib (SU5416)IBA
10/2019
1Carbonic Anhydrases (Carbonic Anhydrase)IBA
10/2019
1Prostaglandins DIBA
10/2019
1Pioglitazone (Actos)FDA Link
10/2019
1Acetazolamide (Diamox)FDA LinkGeneric
10/2019
1Ammonium Chloride (Sal Ammoniac)FDA Link
10/2019
1AntioxidantsIBA
01/2016
1Superoxide DismutaseIBA
01/2016
1InterferonsIBA
01/2016
1Interferon Type IIBA
01/2016
1Histones (Histone)IBA
01/2016
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2012
1Heparitin Sulfate (Heparan Sulfate)IBA
08/2012
1heparanaseIBA
08/2012
1Oxidants (Oxidizing Agents)IBA
07/2012
1ChromatinIBA
07/2012
18-hydroxyguanineIBA
07/2012
1N 30IBA
05/2011
1Growth Differentiation Factor 15IBA
05/2011
1Interleukin-7 (Interleukin 7)IBA
10/2010
1Chemokine ReceptorsIBA
10/2010

Therapy/Procedure

4Therapeutics
01/2023 - 08/2006
4Chemoprevention
10/2019 - 03/2007
2Aftercare (After-Treatment)
10/2019 - 01/2005
2Drug Therapy (Chemotherapy)
05/2002 - 01/2002
1Contraindications
01/2023
1Critical Care (Surgical Intensive Care)
01/2023
1Precision Medicine
01/2022
1Lasers (Laser)
11/2021
1Lung Transplantation
10/2019
1Immunomodulation
01/2016